2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Minimal Hepatic Encephalopathy: new trials by email Literature Review of Minimal Hepatic Encephalopathy trials Research Report on Minimal Hepatic Encephalopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEAL STUDY (Hepatic Encephalopathy and Albumin Study) 25% IV albumin, Placebo - Cirrhosis, Hepatic Encephalopathy | Phase 2 | Completed | Hunter Holmes Mcguire Veteran Affairs Medical Center | 48 | 2018-06-20 | 2022-05-31 |
| Study of Rifaximin in Minimal Hepatic Encephalopathy Rifaximin, rifaximin - Minimal Hepatic Encephalopathy | Phase 1 / Phase 2 | Completed | Hunter Holmes Mcguire Veteran Affairs Medical Center | 20 | 2010-02-01 | 2012-12-11 |
| Study of Lactulose in Children With Chronic Liver Disease Lactulose, placebo - Minimal Hepatic Encephalopathy | Phase 2 | Terminated | Indiana University | 16 | 2009-01-01 | 2014-02-10 |
Fibrosis (2) · Brain Diseases (1) · Hepatic Encephalopathy (1) · Inflammation (1)
Central Nervous System Diseases (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Digestive System Diseases (1) · Hepatic Insufficiency (1) · Liver Diseases (1) · Liver Failure (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Albumins (1) · Lactulose (1) · Rifaximin (1)
Hunter Holmes Mcguire Veteran Affairs Medical Center (2) · Indiana University (1)
United States (3)
Girish Subbarao, M.D. (1) · Jasmohan Bajaj, MD (1) · Jasmohan S Bajaj, MD, MSc (1)